Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
3 back-to-back storms forecast to bring snow and surges of cold air across the Midwest to the Northeast - 2Instructions to Comprehend and Use Open Record Extra Offers
- 3The face is familiar, the name might not be. The king of "Hey, it's that guy!' roles is ready to show you his next act.
- 4The most effective method to Go with Informed Choices on Vehicle Leases
- 5See tonight’s solar storm unfold across the world
- The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- Investigation reveals sperm donor passed on cancer risk to dozens of children across Europe
- FDA updates risk classification for voluntary shredded cheese recall
- Why Cannes Is the Ultimate New Year’s Eve Destination in the South of France’s Off-Season
- 5 Great and High Evaluated Scene Configuration Administrations For 2024
- Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'
- Instructions to Grasp the Innovation Behind 5G Pinnacles\
- Sea Ice Hits New Low in Hottest Year on Record for the Arctic
